OR34-1 Regulation of Breast Cancer Stem Cells by Nuclear Receptor Co-Regulatory Proteins

por Ostrander, Julie, Truong, Thu, Benner, Elizabeth, Lange, Carol
Publicado 2019

THU556 Targeting Breast Cancer Stem Cells With Oncolytic Virus

por Roman Ortiz, Natasha Ivelisse, Danthi, Pranav, Ostrander, Julie Hanson
Publicado 2023

Targeting steroid receptor co-activators to inhibit breast cancer stem cells

por Truong, Thu H., Lange, Carol A., Ostrander, Julie H.
Publicado 2018

OR05-04 Steroid Receptor Co-Activators Complexes Cooperate with Progesterone Receptors (PR) to Reprogram Metabolic Pathways that Drive Therapy Resistant Populations in ER+ Breast C...

por Truong, Thu H, Benner, Elizabeth, Ostrander, Julie Hanson, Lange, Carol A
Publicado 2020

THU477 Drivers Of Estrogen Induced Invasive Lobular Carcinoma

por Ufondu, Chinasa, Clem, Larkin, Musick, Maggie, Sikora, Matthew Joseph, Ostrander, Julie Hanson
Publicado 2023

OR16-2 Steroid Receptor Co-Activator Complexes Regulate Metabolic PFKFB Enzymes to Drive Therapy Resistant ER+ Breast Cancer

por Benner, Elizabeth, Dos Santos, Camila, Hagen, Kyla, Lange, Carol, Ostrander, Julie, Temiz, Nuri, Trousdell, Marygrace, Truong, Thu
Publicado 2022

Cytoplasmic PELP1 and ERRgamma Protect Human Mammary Epithelial Cells from Tam-Induced Cell Death

por Girard, Brian J., Regan Anderson, Tarah M., Welch, Siya Lem, Nicely, Julie, Seewaldt, Victoria L., Ostrander, Julie H.
Publicado 2015

Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK

por Lofgren, Kristopher A, Ostrander, Julie H, Housa, Daniel, Hubbard, Gregory K, Locatelli, Alessia, Bliss, Robin L, Schwertfeger, Kathryn L, Lange, Carol A
Publicado 2011

Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes

por Daniel, Andrea R., Gaviglio, Angela L., Knutson, Todd P., Ostrander, Julie H., D’Assoro, Antonino B., Ravindranathan, Preethi, Peng, Yan, Raj, Ganesh V., Yee, Douglas, Lange, Carol A.
Publicado 2014

Steroid Receptor Co-Activators Regulate Metabolic Kinases to Drive Therapy Resistant ER+ Breast Cancer

por Truong, Thu Ha, Benner, Elizabeth A, Hagen, Kyla M, Temiz, Nuri A, Kerkvliet, Carlos Perez, Wang, Ying, Cortes-Sanchez, Emilio, Yang, Chieh-Hsiang, Pengo, Thomas, Guillen, Katrin P, Welm, Bryan E, Telang, Sucheta, Lange, Carol A, Ostrander, Julie Hanson
Publicado 2021

Evidence for Phenotypic Plasticity in Aggressive Triple-Negative Breast Cancer: Human Biology Is Recapitulated by a Novel Model System

por D’Amato, Nicholas C., Ostrander, Julie H., Bowie, Michelle L., Sistrunk, Christopher, Borowsky, Alexander, Cardiff, Robert D., Bell, Katie, Young, Lawrence J. T., Simin, Karl, Bachelder, Robin E., Delrow, Jeff, Dawson, Alyssa, Yee, Lisa D., Mrózek, Krzysztof, Clay, Timothy M., Osada, Takuya, Seewaldt, Victoria L.
Publicado 2012

PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer

por Truong, Thu H., Benner, Elizabeth A., Hagen, Kyla M., Temiz, Nuri A., Kerkvliet, Carlos Perez, Wang, Ying, Cortes-Sanchez, Emilio, Yang, Chieh-Hsiang, Trousdell, Marygrace C., Pengo, Thomas, Guillen, Katrin P., Welm, Bryan E., Dos Santos, Camila O., Telang, Sucheta, Lange, Carol A., Ostrander, Julie H.
Publicado 2021